A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways
Summary: Mutations in genes essential for mitochondrial function have pleiotropic effects. The mechanisms underlying these traits yield insights into metabolic homeostasis and potential therapies. Here we report the characterization of a mouse model harboring a mutation in the tryptophanyl-tRNA synt...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-12-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124718318710 |
id |
doaj-630a0a3d696840bfb3f385b49f594bbc |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Thomas Agnew Michelle Goldsworthy Carlos Aguilar Anna Morgan Michelle Simon Helen Hilton Chris Esapa Yixing Wu Heather Cater Liz Bentley Cheryl Scudamore Joanna Poulton Karl J. Morten Kyle Thompson Langping He Steve D.M. Brown Robert W. Taylor Michael R. Bowl Roger D. Cox |
spellingShingle |
Thomas Agnew Michelle Goldsworthy Carlos Aguilar Anna Morgan Michelle Simon Helen Hilton Chris Esapa Yixing Wu Heather Cater Liz Bentley Cheryl Scudamore Joanna Poulton Karl J. Morten Kyle Thompson Langping He Steve D.M. Brown Robert W. Taylor Michael R. Bowl Roger D. Cox A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways Cell Reports |
author_facet |
Thomas Agnew Michelle Goldsworthy Carlos Aguilar Anna Morgan Michelle Simon Helen Hilton Chris Esapa Yixing Wu Heather Cater Liz Bentley Cheryl Scudamore Joanna Poulton Karl J. Morten Kyle Thompson Langping He Steve D.M. Brown Robert W. Taylor Michael R. Bowl Roger D. Cox |
author_sort |
Thomas Agnew |
title |
A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways |
title_short |
A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways |
title_full |
A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways |
title_fullStr |
A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways |
title_full_unstemmed |
A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways |
title_sort |
wars2 mutant mouse model displays oxphos deficiencies and activation of tissue-specific stress response pathways |
publisher |
Elsevier |
series |
Cell Reports |
issn |
2211-1247 |
publishDate |
2018-12-01 |
description |
Summary: Mutations in genes essential for mitochondrial function have pleiotropic effects. The mechanisms underlying these traits yield insights into metabolic homeostasis and potential therapies. Here we report the characterization of a mouse model harboring a mutation in the tryptophanyl-tRNA synthetase 2 (Wars2) gene, encoding the mitochondrial-localized WARS2 protein. This hypomorphic allele causes progressive tissue-specific pathologies, including hearing loss, reduced adiposity, adipose tissue dysfunction, and hypertrophic cardiomyopathy. We demonstrate the tissue heterogeneity arises as a result of variable activation of the integrated stress response (ISR) pathway and the ability of certain tissues to respond to impaired mitochondrial translation. Many of the systemic metabolic effects are likely mediated through elevated fibroblast growth factor 21 (FGF21) following activation of the ISR in certain tissues. These findings demonstrate the potential pleiotropy associated with Wars2 mutations in patients. : A reduced-function mutation in the nuclear-encoded, mitochondrial-localized Wars2 gives rise to deafness, reduced and abnormal fat, and hypertrophic cardiomyopathy. Agnew et al. show that the different tissue effects of this mutation arise from variable activation of stress response pathways and tissue-specific responses to impaired mitochondrial function. Keywords: WARS2, deafness, adiposity, hypertrophic cardiomyopathy, pleiotropic, ISR, mitochondrial dysfunction |
url |
http://www.sciencedirect.com/science/article/pii/S2211124718318710 |
work_keys_str_mv |
AT thomasagnew awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT michellegoldsworthy awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT carlosaguilar awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT annamorgan awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT michellesimon awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT helenhilton awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT chrisesapa awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT yixingwu awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT heathercater awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT lizbentley awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT cherylscudamore awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT joannapoulton awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT karljmorten awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT kylethompson awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT langpinghe awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT stevedmbrown awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT robertwtaylor awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT michaelrbowl awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT rogerdcox awars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT thomasagnew wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT michellegoldsworthy wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT carlosaguilar wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT annamorgan wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT michellesimon wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT helenhilton wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT chrisesapa wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT yixingwu wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT heathercater wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT lizbentley wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT cherylscudamore wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT joannapoulton wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT karljmorten wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT kylethompson wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT langpinghe wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT stevedmbrown wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT robertwtaylor wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT michaelrbowl wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways AT rogerdcox wars2mutantmousemodeldisplaysoxphosdeficienciesandactivationoftissuespecificstressresponsepathways |
_version_ |
1724905104317874176 |
spelling |
doaj-630a0a3d696840bfb3f385b49f594bbc2020-11-25T02:13:27ZengElsevierCell Reports2211-12472018-12-01251233153328.e6A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response PathwaysThomas Agnew0Michelle Goldsworthy1Carlos Aguilar2Anna Morgan3Michelle Simon4Helen Hilton5Chris Esapa6Yixing Wu7Heather Cater8Liz Bentley9Cheryl Scudamore10Joanna Poulton11Karl J. Morten12Kyle Thompson13Langping He14Steve D.M. Brown15Robert W. Taylor16Michael R. Bowl17Roger D. Cox18MRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKNuffield Department of Obstetrics and Gynaecology, University of Oxford, Level 3 The Women’s Centre, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UKNuffield Department of Obstetrics and Gynaecology, University of Oxford, Level 3 The Women’s Centre, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UKWellcome Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UKWellcome Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UKWellcome Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UKMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UK; Corresponding authorMRC Harwell Institute, Mammalian Genetics Unit and Mary Lyon Centre, Harwell Campus, Oxfordshire OX11 0RD, UK; Corresponding authorSummary: Mutations in genes essential for mitochondrial function have pleiotropic effects. The mechanisms underlying these traits yield insights into metabolic homeostasis and potential therapies. Here we report the characterization of a mouse model harboring a mutation in the tryptophanyl-tRNA synthetase 2 (Wars2) gene, encoding the mitochondrial-localized WARS2 protein. This hypomorphic allele causes progressive tissue-specific pathologies, including hearing loss, reduced adiposity, adipose tissue dysfunction, and hypertrophic cardiomyopathy. We demonstrate the tissue heterogeneity arises as a result of variable activation of the integrated stress response (ISR) pathway and the ability of certain tissues to respond to impaired mitochondrial translation. Many of the systemic metabolic effects are likely mediated through elevated fibroblast growth factor 21 (FGF21) following activation of the ISR in certain tissues. These findings demonstrate the potential pleiotropy associated with Wars2 mutations in patients. : A reduced-function mutation in the nuclear-encoded, mitochondrial-localized Wars2 gives rise to deafness, reduced and abnormal fat, and hypertrophic cardiomyopathy. Agnew et al. show that the different tissue effects of this mutation arise from variable activation of stress response pathways and tissue-specific responses to impaired mitochondrial function. Keywords: WARS2, deafness, adiposity, hypertrophic cardiomyopathy, pleiotropic, ISR, mitochondrial dysfunctionhttp://www.sciencedirect.com/science/article/pii/S2211124718318710 |